AST

Comparison of AI-assisted and manual zone interpretation of Nitroxoline in uncomplicated urinary tract infections.
by admin|08 May 2023|APAS Independence, APAS-AMR analysis module, AST, Conference Posters
Nitroxoline is one of the recommended first-line drugs for the treatment of uncomplicated urinary tract infections (uUTIs), but it is not included in the usual panels of automated susceptibility testing (AST) platform systems, such as MicroScan or Vitek.
continue reading
Direct antimicrobial susceptibility testing for acute urinary tract infection – comparison of AI-assisted zone interpretation and conventional susceptibility testing methods.
by admin|08 May 2023|APAS Independence, APAS-AMR analysis module, AST, Conference Posters
Direct antimicrobial susceptibility testing (dAST) from urine samples using disc diffusion methods is in widespread use in some countries, allowing for the provision of results earlier than traditional AST methods, at a lower cost.
continue reading
Artificial intelligence (AI)-assisted antimicrobial susceptibility testing (AST): Automated imaging and the use of artificial intelligence for interpretation of disc-diffusion AST according to EUCAST, including rapid antimicrobial susceptibility testing (RAST)
by admin|27 April 2022|APAS Independence, APAS-AMR analysis module, AST, Conference Posters
Disc diffusion remains an essential part of AST and EUCAST has recently expanded its guidelines to include breakpoints for rapid disc diffusion reading at 4, 6 or 8 hours.
continue reading